NCT05517278

Clinical Evaluation of the Next Science SurgX Antimicrobial Wound Gel Impact on Surgical Site Complications

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Northwell Health · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This is a single-site, prospective, clinical study of subjects that are scheduled to undergo either total hip or total knee arthroplasties. It is anticipated that surgical wounds treated with SurgX will exhibit reduced surgical site complication rates and improved post-operative treatment outcomes by potentially decreasing site bioburden of both free-floating and biofilm-entrenched organisms.

Conditions

• Total Hip Arthroplasty
• Total Knee Arthroplasty

Interventions

Type	Name	Description
OTHER	SurgX Antimicrobial Wound Gel	In addition to standard of care, at time of surgery, SurgX applied on the incision after closure and then re-applied at the time of first bandage change on day of discharge.
OTHER	Standard of Care	The control group will receive standard of care.

Timeline

• Start date: 2024-01-01
• Primary completion: 2024-07-15
• Completion: 2024-07-15
• First posted: 2022-08-26
• Last updated: 2025-05-23

Locations

3 sites across 1 country: United States